Sponsor Pipeline

Santen SAS Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06514612 LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline… Acquired Blepharophimosis Recruiting
Not specified
NCT07235592 PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group Primary Open Angle Glaucoma Recruiting
NCT04685109 3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to… Dry Eye Syndromes Active, Not Recruiting
Get alerts when Santen SAS's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free